Home > Healthcare > Medical Devices > Therapeutic Devices > Carboxy Therapy Market

Carboxy Therapy Market Share

Report ID: GMI6463
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Carboxy Therapy Market Share

Some of the eminent market participants operating in the carboxy therapy market include:

DTA Medical
Cosmopro
Carbossiterapia Italiana
Mezopharma
MBE Medical Divisions
Beijing Jontelaser Technologies Co., Ltd.
Alvi Prague
Kastner-Praxisbedarf
MEDAiON Plasma
Easymedical Group
Innoaesthetics.

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, new product development and launches to strengthen their product portfolio as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global market for carboxy therapy was valued at USD 98.4 million in 2022 and is estimated to account for USD 310.5 million by 2032, owing to the rising demand for non-surgical cosmetic procedures.

The aesthetic medicine segment garnered USD 28.9 million revenue size in the year 2022, backed by the carboxy therapy's versatile cosmetic applications, addressing concerns such as cellulite, stretch marks, and dark circles that attracts a large number of patients seeking non-surgical alternatives.

U.S. carboxy therapy market accounted for USD 36.4 million in 2022 and is predicted to witness substantial growth through 2032. Advanced healthcare infrastructure ensuring widespread accessibility to safe & effective carboxy therapy services for aesthetic treatments will accelerate market growth.

DTA Medical, Cosmopro, Carbossiterapia Italiana, Mezopharma, MBE Medical Divisions, Beijing Jontelaser Technologies Co., Ltd., Alvi Prague, Kastner-Praxisbedarf, MEDAiON Plasma, Easymedical Group, and Innoaesthetics.